These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 3278167)
1. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167 [TBL] [Abstract][Full Text] [Related]
2. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas. Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692 [No Abstract] [Full Text] [Related]
3. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma. Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma. Putzki H; Student A; Jablonski M; Heymann H Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817 [TBL] [Abstract][Full Text] [Related]
5. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution]. Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631 [No Abstract] [Full Text] [Related]
6. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms]. Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886 [TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer]. Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467 [No Abstract] [Full Text] [Related]
8. Tissue polypeptide antigen - a new tumour marker? Wagner W; Husemann B; Becker H; Groitl H; Koerfgen HP; Hammerschmidt M Aust N Z J Surg; 1982 Feb; 52(1):41-3. PubMed ID: 6951549 [No Abstract] [Full Text] [Related]
9. [Clinical evaluation of tumor markers in patients with colorectal cancer]. Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727 [TBL] [Abstract][Full Text] [Related]
10. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9. Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors]. Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744 [No Abstract] [Full Text] [Related]
12. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine. Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G Acta Radiol Oncol; 1984; 23(1):27-32. PubMed ID: 6328884 [TBL] [Abstract][Full Text] [Related]
13. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172 [TBL] [Abstract][Full Text] [Related]
14. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen. Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729 [TBL] [Abstract][Full Text] [Related]
15. Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer. Falcone F; Sabbatani S; Fini A; Turba E; Magri P; D'Ales A Nucl Med Commun; 1985 May; 6(5):299-304. PubMed ID: 4034127 [TBL] [Abstract][Full Text] [Related]
16. [Experience in the use of the tumor markers CEA, GICA and TPA in the postoperative monitoring of colorectal neoplasms]. Morelli M; Nardi M; Valle M; Balducci D; Serafini D; Bernardini P Minerva Med; 1985 Sep; 76(34-35):1529-31. PubMed ID: 2412188 [TBL] [Abstract][Full Text] [Related]
17. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers]. Kataoka A; Yakushiji M Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782 [TBL] [Abstract][Full Text] [Related]
18. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison. von Kleist S Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321 [TBL] [Abstract][Full Text] [Related]
19. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9]. Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003 [No Abstract] [Full Text] [Related]
20. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]